Maaike P.G. Vreeswijk

6.1k citations

50 papers · 1.7k indexed · h-index 22

Co-authors: Harry Vrieling Peter Devilee Christi J. van Asperen Jan H.J. Hoeijmakers A.A. van Zeeland Dik C. van Gent Carolien H. M. van Deurzen Roland Kanaar
Topics: DNA Repair Mechanisms (25 papers)BRCA gene mutations in cancer (25 papers)CRISPR and Genetic Engineering (17 papers)
Cited by: Cancer Research Genetics Reproductive Medicine
Journals: Journal of Biological Chemistry Nature CommunicationsSHILAP Revista de lepidopterología
Partner nations: Netherlands United Kingdom United States

In The Last Decade

Maaike P.G. Vreeswijk

50 papers receiving 1.7k citations

Peers

Countries citing papers authored by Maaike P.G. Vreeswijk

Since Specialization

Citations

This map shows the geographic impact of Maaike P.G. Vreeswijk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maaike P.G. Vreeswijk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maaike P.G. Vreeswijk more than expected).

Fields of papers citing papers by Maaike P.G. Vreeswijk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maaike P.G. Vreeswijk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maaike P.G. Vreeswijk. The network helps show where Maaike P.G. Vreeswijk may publish in the future.

Co-authorship network of co-authors of Maaike P.G. Vreeswijk

This figure shows the co-authorship network connecting the top 25 collaborators of Maaike P.G. Vreeswijk. A scholar is included among the top collaborators of Maaike P.G. Vreeswijk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maaike P.G. Vreeswijk. Maaike P.G. Vreeswijk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Systematic Minigene-Based Splicing Analysis and Tentative Clinical Classification of 52 CHEK2 Splice-Site Variants 2023 ·Clinical Chemistry ·(unknown),(unknown),Elena Bueno‐Martínez,(unknown),(unknown),(unknown),(unknown),Pedro Pérez‐Segura,Mar Infante,Douglas F. Easton,Peter Devilee,Maaike P.G. Vreeswijk,Miguel de la Hoya,Eladio A. Velasco	5
2	RAD51 as a biomarker for homologous recombination deficiency in high‐grade serous ovarian carcinoma: robustness and interobserver variability of the RAD51 test 2023 ·The Journal of Pathology Clinical Research ·(unknown),Alba Llop‐Guevara,Elisa Yaniz‐Galende,Benedetta Pellegrino,Natalja T. ter Haar,(unknown),Nicoletta Campanini,Antonino Musolino,Tjalling Bosse,Alexandra Léary,Violeta Serra,Maaike P.G. Vreeswijk	3
3	Performance of a RAD51-based functional HRD test on paraffin-embedded breast cancer tissue 2023 ·Breast Cancer Research and Treatment ·Lise M. van Wijk,(unknown),Natalja T. ter Haar,(unknown),(unknown),Harry Vrieling,Danielle Cohen,Maaike P.G. Vreeswijk	2
4	CHEK2 variants: linking functional impact to cancer risk 2022 ·Trends in cancer ·Rick A.C.M. Boonen,Maaike P.G. Vreeswijk,Haico van Attikum	21
5	Functional Analysis Identifies Damaging CHEK2 Missense Variants Associated with Increased Cancer Risk 2021 ·Cancer Research ·Rick A.C.M. Boonen,Wouter W. Wiegant,(unknown),Bas Vroling,(unknown),Zsofia Kote‐Jarai,Martina Mijušković,Simona Cristea,(unknown),Tom van Wezel,Niko Beerenwinkel,Rosalind A. Eeles,Peter Devilee,Maaike P.G. Vreeswijk,Giancarlo Marra,Haico van Attikum	33
6	Functional Categorization of BRCA1 Variants of Uncertain Clinical Significance in Homologous Recombination Repair Complementation Assays 2020 ·Clinical Cancer Research ·Peter Bouwman,Ingrid van der Heijden,Hanneke van der Gulden,Roebi de Bruijn,(unknown),Setareh Moghadasi,Lodewyk F.A. Wessels,(unknown),Maaike P.G. Vreeswijk,Jos Jonkers	20
7	Variants of uncertain clinical significance in hereditary breast and ovarian cancer genes: best practices in functional analysis for clinical annotation 2020 ·Journal of Medical Genetics ·Álvaro N.A. Monteiro,Peter Bouwman,Arne Nedergaard Kousholt,Diana Eccles,Gaël A. Millot,Jean‐Yves Masson,Marjanka K. Schmidt,Shyam K. Sharan,Ralph Scully,Lisa Wiesmüller,Fergus J. Couch,Maaike P.G. Vreeswijk	32
8	Germline BRCA -Associated Endometrial Carcinoma Is a Distinct Clinicopathologic Entity 2019 ·Clinical Cancer Research ·Marthe M. de Jonge,Lauren L. Ritterhouse,Cor D. de Kroon,Maaike P.G. Vreeswijk,Jeremy P. Segal,(unknown),Harry Hollema,Matti A. Rookus,Christi J. van Asperen,Flora E. van Leeuwen,Vincent T.H.B.M. Smit,Brooke E. Howitt,Tjalling Bosse	34
9	Functional analysis of genetic variants in the high-risk breast cancer susceptibility gene PALB2 2019 ·Nature Communications ·Rick A.C.M. Boonen,Amélie Rodrigue,Chantal Stoepker,Wouter W. Wiegant,Bas Vroling,(unknown),Magdalena B. Rother,(unknown),Maaike P.G. Vreeswijk,Fergus J. Couch,Jacques Simard,Peter Devilee,Jean‐Yves Masson,Haico van Attikum	40
10	Frequent Homologous Recombination Deficiency in High-grade Endometrial Carcinomas 2018 ·Clinical Cancer Research ·Marthe M. de Jonge,Aurélie Auguste,Lise M. van Wijk,Philip C. Schouten,Matty Meijers,Natalja T. ter Haar,Vincent T.H.B.M. Smit,Remi A. Nout,Mark A. Glaire,David N. Church,Harry Vrieling,Bastien Job,Yannick Boursin,Cor D. de Kroon,Étienne Rouleau,Alexandra Léary,Maaike P.G. Vreeswijk,Tjalling Bosse	119
11	Performance of BRCA1/2 mutation prediction models in male breast cancer patients 2017 ·Clinical Genetics ·Setareh Moghadasi,(unknown),Luc Janssen,(unknown),Mar Rodríguez‐Girondo,Wendy A.G. van Zelst–Stams,Jan C. Oosterwijk,Margreet G.E.M. Ausems,Reinhard Oldenburg,Muriel A. Adank,Eveline W Blom,Mariëlle Ruijs,Theo A.M. van Os,Carolien H. M. van Deurzen,(unknown),(unknown),Juul Wijnen,Maaike P.G. Vreeswijk,Christi J. van Asperen	3
12	Linking uterine serous carcinoma to BRCA1/2-associated cancer syndrome: A meta-analysis and case report 2017 ·European Journal of Cancer ·Marthe M. de Jonge,Antien L. Mooyaart,Maaike P.G. Vreeswijk,Cor D. de Kroon,Tom van Wezel,Christi J. van Asperen,Vincent T.H.B.M. Smit,Olaf M. Dekkers,Tjalling Bosse	41
13	The effects of short-term fasting on tolerance to (neo) adjuvant chemotherapy in HER2-negative breast cancer patients: a randomized pilot study 2015 ·BMC Cancer ·Stefanie de Groot,Maaike P.G. Vreeswijk,Marij J.P. Welters,Gido Gravesteijn,J.J.W.A. Boei,Anouk Jochems,Daniel Houtsma,Hein Putter,(unknown),J.W.R. Nortier,Hanno Pijl,Judith R. Kroep	173
14	Functional Ex Vivo Assay to Select Homologous Recombination–Deficient Breast Tumors for PARP Inhibitor Treatment 2014 ·Clinical Cancer Research ·Kishan A.T. Naipal,Nicole S. Verkaik,Najim Ameziane,Carolien H. M. van Deurzen,Petra ter Brugge,Matty Meijers,Anieta M. Sieuwerts,John W.M. Martens,Mark J. O’Connor,Harry Vrieling,Jan H.J. Hoeijmakers,Jos Jonkers,Roland Kanaar,Johan P. de Winter,Maaike P.G. Vreeswijk,Agnes Jager,Dik C. van Gent	124
15	Functional Assays for Analysis of Variants of Uncertain Significance inBRCA2 2013 ·Human Mutation ·Lucia Guidugli,Aura Carreira,Sandrine M. Caputo,Åsa Ehlén,Alvaro Galli,Álvaro N.A. Monteiro,Susan L. Neuhausen,Thomas van Overeem Hansen,Fergus J. Couch,Maaike P.G. Vreeswijk	82
16	A guide for functional analysis ofBRCA1variants of uncertain significance 2012 ·Human Mutation ·Gaël A. Millot,Marcelo A. Carvalho,Sandrine M. Caputo,Maaike P.G. Vreeswijk,Melissa A. Brown,Michelle Webb,Étienne Rouleau,Susan L. Neuhausen,Thomas van Overeem Hansen,Alvaro Galli,Rita D. Brandão,Marinus J. Blok,Aneliya Velkova,Fergus J. Couch,Álvaro N.A. Monteiro	82
17	Analysis and Interpretation of RNA Splicing Alterations in Genes Involved in Genetic Disorders 2012 ·Methods in molecular biology ·Maaike P.G. Vreeswijk,Heleen M. van der Klift	11
18	Site-specific analysis of UV-induced cyclobutane pyrimidine dimers in nucleotide excision repair-proficient and -deficient hamster cells: Lack of correlation with mutational spectra 2008 ·Mutation research. Fundamental and molecular mechanisms of mutagenesis ·Maaike P.G. Vreeswijk,(unknown),Micheline Giphart-Gassler,Harry Vrieling,A.A. van Zeeland,Leon H.F. Mullenders,Wil A. M. Loenen	4
19	Intronic variants inBRCA1andBRCA2that affect RNA splicing can be reliably selected by splice-site prediction programs 2008 ·Human Mutation ·Maaike P.G. Vreeswijk,Jaco Kraan,Heleen M. van der Klift,Geraldine R. Vink,Cees J. Cornelisse,Juul Wijnen,Egbert Bakker,Christi J. van Asperen,Peter Devilee	68
20	Deficient global genome repair of UV-induced cyclobutane pyrimidine dimers in terminally differentiated myocytes and proliferating fibroblasts from the rat heart 2003 ·DNA repair ·(unknown),Maaike P.G. Vreeswijk,(unknown),Arnoud van der Laarse,A.A. van Zeeland,Leon H.F. Mullenders	19

About Maaike P.G. Vreeswijk

Maaike P.G. Vreeswijk is a scholar working on Genetics, Cancer Research and Reproductive Medicine, having authored 50 papers that have together received 1.7k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (25 papers), BRCA gene mutations in cancer (25 papers) and CRISPR and Genetic Engineering (17 papers). The work is most often cited by research in Cancer Research (363 citations), Genetics (649 citations) and Reproductive Medicine (189 citations). Maaike P.G. Vreeswijk has collaborated with scholars based in Netherlands, United Kingdom and United States. Frequent co-authors include Harry Vrieling, Peter Devilee, Christi J. van Asperen, Jan H.J. Hoeijmakers, A.A. van Zeeland, Dik C. van Gent, Carolien H. M. van Deurzen, Roland Kanaar, Marthe M. de Jonge and Kishan A.T. Naipal. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact